Microbiological findings in febrile neutropenia

被引:80
作者
Gaytán-Martínez, J
Mateos-García, E
Sánchez-Cortés, E
González-Llaven, J
Casanova-Cardiel, LJ
Fuentes-Allen, JL
机构
[1] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Hosp Infectol, Dept Infectol, Mexico City, DF, Mexico
[2] Inst Mexicano Seguro Social, Ctr Med Nacl Raza, Hosp Especialidades, Dept Hematol, Mexico City, DF, Mexico
关键词
febrile neutropenia; bacteremia; bone-marrow transplantation; leukemia;
D O I
10.1016/S0188-4409(00)00080-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. This study was carried out to assess the isolation rate of bacterial and fungal causative agents in Mexican neutropenic adults with hematological neoplasia. Methods. A prospective observational survey involving 120 consecutive episodes of febrile neutropenia during 1 year was carried out. These episodes were observed in 630 patients discharged with diagnoses of leukemia or lymphoma, or after bone-marrow transplantation. Results. At least one pathogen was isolated in 42 of 120 episodes (35%), and was present in 39 patients with acute myeloid leukemia (AML) (43%), acute lymphoblastic leukemia (ALL) (23%), and in patients who underwent bone-marrow transplantation (20%). Primary bacteremia was the most frequent cause of fever (24 episodes, 57%), followed by intravascular device-related infections (5 episodes, 17%), and soft-tissue infections (5 episodes, 15%). Escherichia coli (33%) was the most frequently isolated agent of primary bacteremia, followed by coagulase-negative Staphylococcus (29%.), and Klebsiella oxytoca (16%). Fungal infection was responsible for five events (4%): two episodes of pneumonia (Penicillium marneffei and Aspergillus fumigatus, one event each); two cases of fungemia, one due to Candida tropicalis and one to Rhodotorula gluttinis, and one cryptococcal meningitis event. Conclusions. The isolation rate, approximately 30%, was in accordance with previous reports; similar percentages of Gram-positive and Gram-negative isolates were found. A remarkably low rate of viridans group streptococci and fungal agents was observed, despite the fact that neutropenia is the main risk factor for infection due to these agents. Studies reporting local microbiological findings are necessary because they support an antibiotic choice for prophylaxis or therapy more accurately than reports from other areas. (C) 2000 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:388 / 392
页数:5
相关论文
共 20 条
  • [1] [Anonymous], 1991, J Infect Dis, V163, P951
  • [2] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI THAT ARE HIGHLY RESISTANT TO PENICILLIN - INCREASE AMONG NEUTROPENIC PATIENTS WITH CANCER
    CARRATALA, J
    ALCAIDE, F
    FERNANDEZSEVILLA, A
    CORBELLA, X
    LINARES, J
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1169 - 1173
  • [3] Antibiotic treatment of febrile episodes in neutropenic cancer patients - Clinical and economic considerations
    deLalla, F
    [J]. DRUGS, 1997, 53 (05) : 789 - 804
  • [4] Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation
    Denning, DW
    Evans, EGV
    Kibbler, CC
    Richardson, MD
    Roberts, MM
    Rogers, TR
    Warnock, DW
    Warren, RE
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (06) : 424 - 436
  • [5] Fever in the compromised host
    Donowitz, GR
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1996, 10 (01) : 129 - &
  • [6] PROLONGED GRANULOCYTOPENIA - THE MAJOR RISK FACTOR FOR INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH ACUTE-LEUKEMIA
    GERSON, SL
    TALBOT, GH
    HURWITZ, S
    STROM, BL
    LUSK, EJ
    CASSILETH, PA
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) : 345 - 351
  • [7] 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
    Hughes, WT
    Armstrong, D
    Bodey, GP
    Brown, AE
    Edwards, JE
    Feld, R
    Pizzo, P
    Rolston, KVI
    Shenep, JL
    Young, LS
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 551 - 573
  • [8] GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER
    HUGHES, WT
    ARMSTRONG, D
    BODEY, GP
    FELD, R
    MANDELL, GL
    MEYERS, JD
    PIZZO, PA
    SCHIMPFF, SC
    SHENEP, JL
    WADE, JC
    YOUNG, LS
    YOW, MD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) : 381 - 396
  • [9] Science and pragmatism in the treatment and prevention of neutropenic infection
    Klastersky, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 13 - 24
  • [10] Antifungal prophylaxis during neutropenia and immunodeficiency
    Lortholary, O
    Dupont, B
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (03) : 477 - +